Wealth Enhancement Advisory Services, LLC Altimmune, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $46.2 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 9,632 shares of ALT stock, worth $66,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,632
Previous 9,632
-0.0%
Holding current value
$66,460
Previous $59,000
16.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
192Shares Held
39.1MCall Options Held
926KPut Options Held
743K-
Black Rock Inc. New York, NY5.32MShares$36.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.98MShares$34.4 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.88MShares$26.7 Million0.01% of portfolio
-
State Street Corp Boston, MA3.41MShares$23.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$19 Million1.44% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $338M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...